Alliancebernstein LP Sells 68950 Shares of Array BioPharma Inc. (ARRY)

The fund owned 450,202 shares of the biopharmaceutical company's stock after purchasing an additional 9,794 shares during the quarter. Array BioPharma earned a news sentiment score of 0.14 on Accern's scale. Array Biopharma Inc (NASDAQ:ARRY) has risen 176.51% since October 15, 2016 and is uptrending. Finally, Goldman Sachs Group Inc. boosted its holdings in shares of Array BioPharma by 149.6% in the first quarter. Vanguard Group Inc. now owns 16,993,415 shares of the biopharmaceutical company's stock valued at $151,921,000 after purchasing an additional 6,156,120 shares in the last quarter. Teacher Retirement System of Texas grew its stake in shares of Array BioPharma by 8.3% in the 2nd quarter. Caxton Associates LP acquired a new position in shares of Array BioPharma in the 1st quarter worth approximately $142,000. State Street Corp boosted its holdings in Array BioPharma by 28.6% in the first quarter. Geode Capital Management LLC now owns 1,566,152 shares of the biopharmaceutical company's stock worth $14,000,000 after acquiring an additional 113,632 shares during the period.

01/30/2017 - Array BioPharma Inc. was downgraded to "market perform" by analysts at Leerink Swann. Prudential Financial Inc. now owns 17,377 shares of the biopharmaceutical company's stock worth $155,000 after purchasing an additional 590 shares during the last quarter. Institutional investors own 85.64% of the company's stock.

TRADEMARK VIOLATION NOTICE: This piece was originally reported by Week Herald and is the sole property of of Week Herald. If you are accessing this news story on another domain, it was stolen and reposted in violation of US and global copyright and trademark law. Array BioPharma had 24 analyst reports since June 3, 2016 according to SRatingsIntel.

Array BioPharma Inc. has a one year low of $5.36 and a one year high of $13.40. (ARRY) opened at 12.36 on Friday. On Friday, October 16 the stock rating was upgraded by RBC Capital Markets to "Best Ideas List".

It is now trading at $12.36 which is well above $11.22, the 50 day moving average and which is quite a bit above the 200 day moving average of $9.00. Artal Group Sa acquired 200,000 shares as Array Biopharma Inc (ARRY)'s stock declined 27.53%.

As of the last earnings report the EPS was $-0.72 and is projected to be $-0.99 for the current year with 171,442,000 shares outstanding. Array BioPharma had a negative return on equity of 1,187.18% and a negative net margin of 77.44%. The business had revenue of $33.80 million during the quarter, compared to the consensus estimate of $28.64 million. The Miller Howard Investments Inc holds 1.46 million shares with $65.79M value, up from 686,155 last quarter. The company's revenue was down 21.8% on a year-over-year basis. Cambiar Investors Ltd Llc reported 0.14% of its portfolio in Array Biopharma Inc (NASDAQ:ARRY).

In related news, Director Kyle Lefkoff sold 38,865 shares of the firm's stock in a transaction dated Friday, September 29th. The shares were sold at an average price of $12.31, for a total transaction of $478,428.15. Following the completion of the sale, the director now directly owns 51,585 shares of the company's stock, valued at approximately $635,011.35. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 3.18% of the company's stock.

These firms have modified their investment in ARRY. Cantor Fitzgerald set a $13.00 target price on shares of Array BioPharma and gave the stock a "buy" rating in a report on Wednesday, August 9th. Stifel Nicolaus reissued a "buy" rating and issued a $13.00 target price on shares of Array BioPharma in a report on Thursday, August 10th. Jefferies Group LLC reiterated a "buy" rating and issued a $9.00 price objective on shares of Array BioPharma in a research report on Tuesday, September 12th. Finally, J P Morgan Chase & Co restated a "buy" rating and issued a $14.00 price objective on shares of Array BioPharma in a research report on Monday, September 11th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and seven have issued a buy rating to the stock. The value of the company's investment in Array BioPharma Inc. increased from $3,129,000 to $3,557,000 increasing 13.7% quarter to quarter.

Array BioPharma Inc is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.

Notícias recomendadas

  • Verition Fund Management LLC Trims Position in Canadian Natural Resources Limited (CNQ)

    The fund owned 698,280 shares of the oil and gas producer's stock after purchasing an additional 83,825 shares during the quarter. Oxford Asset Management bought a new stake in Canadian Natural Resources Limited during the 1st quarter worth about $212,000.
    Manchester City are the best team in Europe, says Raul Albiol

    Manchester City are the best team in Europe, says Raul Albiol

    Top of Group F with six points from their opening two games, Pep Guardiola's men are 8/13 (1.62 ) favourites with dabblebet to maintain their 100 per cent record by coming out on top here.
    Delta Air Lines, Inc

    Delta Air Lines, Inc

    Bastian Edward H had sold 25,000 shares worth $1.21M. $1.32 million worth of stock was sold by West W Gilbert on Friday, May 26. It has underperformed by 4.87% the S&P500. (NYSE: DAL ) saw a large decline in short interest during the month of September.
  • NASA satellite sees overheated tropical forests oozing with carbon dioxide

    The team compared that data to 2011 as a reference year, when weather and carbon cycle processes were normal. However, 2015 and 2016 saw an unequalled increase.
    Le nom d'Harvey Weinstein a été effacé des planches de Deauville

    Le nom d'Harvey Weinstein a été effacé des planches de Deauville

    Puisse cette affaire contribuer à dénoncer une nouvelle fois des pratiques graves et inacceptables", concluaient-ils. Le maire de Deauville, Philippe Augier, a pris la décision d'effacer le nom d'Harvey Weinstein des planches.
    Deadly jellyfish-like creature reportedly spotted on Portsmouth beach

    Deadly jellyfish-like creature reportedly spotted on Portsmouth beach

    The siphonophore - a similar creature to a jellyfish - causes an incredibly painful sting which in some cases can prove fatal. The UK Coastguard has received multiple reports of Portuguese Man o' War washing up on the Dorset and Devon coast.
  • Son coup de gueule aux détracteurs de sa série — Mimie Mathy

    Son coup de gueule aux détracteurs de sa série — Mimie Mathy

    N'allez pas croire que la recette du succès de la série " Joséphine Ange gardien " se tient en un claquement de doigt. Et que les fans de la série se rassurent, la fin n'est pas encore à l'ordre du jour.

    Lenox Wealth Management Inc. Takes Position in Wpp Plc (NASDAQ:WPPGY)

    TRADEMARK VIOLATION WARNING: This story was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. Deutsche Bank AG lowered shares of Wpp Plc from a "buy" rating to a "hold" rating in a research note on Monday, July 17th.

    Arrowstreet Capital Limited Partnership Boosts Stake in SodaStream International Ltd. (SODA)

    Zacks' sales calculations are a mean average based on a survey of research analysts that follow Sodastream International. The stock of Sodastream International Ltd (NASDAQ:SODA) has "Hold" rating given on Wednesday, December 16 by Jefferies.
  • ArcBest Corporation (ARCB) Lowered to

    ArcBest Corporation (ARCB) Lowered to "Market Perform" at Cowen and Company

    The share price of ArcBest Corporation (NASDAQ: ARCB ) was down -4.26% during the last trading session, with a day high of 33.10. Eagle Boston Investment Management Inc. boosted its position in shares of ArcBest Corporation by 39.4% during the 2nd quarter.
    Ed Sheeran s'est fait renverser par une voiture

    Ed Sheeran s'est fait renverser par une voiture

    Il intervient à quelques jours d'une grande tournée en Asie que l'artiste doit entamer le 22 octobre à Taipei, puis Osaka et Séoul notamment.
    New Razer Smartphone Poses For The Camera

    New Razer Smartphone Poses For The Camera

    Ever since then, many started considering that the question related to Razer's release of a smartphone is a "when" not an "if". It will be powered by Qualcomm's top-end Snapdragon 835 processor coupled with massive 8GB of RAM and Adreno 540 for graphics.

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.